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Abstract
Recognition of pathogens is performed by specific receptors in cells of the innate immune system, which may undergo
modulation during the continuum of clinical manifestations of sepsis. Monocytes and neutrophils play a key role in host
defense by sensing and destroying microorganisms. This study aimed to evaluate the expression of CD14 receptors on
monocytes; CD66b and CXCR2 receptors on neutrophils; and TLR2, TLR4, TLR5, TLR9, and CD11b receptors on both cell
types of septic patients. Seventy-seven septic patients (SP) and 40 healthy volunteers (HV) were included in the study, and
blood samples were collected on day zero (D0) and after 7 days of therapy (D7). Evaluation of the cellular receptors was
carried out by flow cytometry. Expression of CD14 on monocytes and of CD11b and CXCR2 on neutrophils from SP was
lower than that from HV. Conversely, expression of TLR5 on monocytes and neutrophils was higher in SP compared with HV.
Expression of TLR2 on the surface of neutrophils and that of TLR5 on monocytes and neutrophils of SP was lower at D7
than at D0. In addition, SP who survived showed reduced expression of TLR2 and TLR4 on the surface of neutrophils at D7
compared to D0. Expression of CXCR2 for surviving patients was higher at follow-up compared to baseline. We conclude that
expression of recognition and cell signaling receptors is differentially regulated between SP and HV depending on the recep-
tor being evaluated.
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Introduction
Sepsis has been defined as a systemic inflammatory
response syndrome triggered by infection (1). However, a
state of sepsis-induced immunosuppression is increas-
ingly demonstrated in experimental (2,3) and clinical
sepsis (4). It has now been recognized that most patients
dying from sepsis present evidence of unresolved septic
foci and immunosuppression (5). We found that
decreased or exacerbated responses are observed over
the course of the clinical manifestations, depending on the
functions and cells evaluated (6).
Bacterial sensing and cell signaling involve complex
mechanisms and are modulated during sepsis (7).
Specialized phagocytes, such as neutrophils and mono-
cytes, play an important role in host defense and are
critical cellular components of the innate immune system.
These cells have the ability to recognize and engulf
pathogens, responding with the production of inflamma-
tory mediators and coordinating additional mechanisms,
such as the recruitment of polymorphonuclear cells from
the peripheral blood to the site of infection, ultimately
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leading to the resolution of the infection. The immune
response to bacterial infection is triggered when pattern
recognition receptors on phagocytes, including the Toll-
like receptors (TLRs), recognize the pathogen-associated
molecular patterns (PAMPs) expressed by the infecting
microorganism (8).
TLRs are expressed both on the cell surface and
intracellularly and recognize PAMPs aswell as endogenous
mediators (8). TLR1, TLR2, TLR4, TLR5, and TLR6 are
expressed on the cell surface, whereas TLR3, TLR7, TLR8,
and TLR9 are located in intracellular compartments (9).
There is some specificity between TLRs and the
microbial structures that they recognize. TLR2 is a
promiscuous receptor that recognizes multiple ligands
expressed on a variety of microorganisms, acts in
conjunction with TLR1 or TLR6, and is stimulated by
bacterial cell wall peptidoglycan (PGN) and lipoteichoic
acid (9). TLR4/myeloid differentiation protein-2, in asso-
ciation with the coreceptor CD14, recognizes lipopolysac-
charide (LPS) (7). CD14 is present in two forms:
membrane-bound CD14 (mCD14) and soluble CD14
(sCD14). CD14 plays a major role in LPS recognition,
and it was recently shown to also recognize Gram-positive
bacteria (10). TLR5 is activated by bacterial flagellin and
TLR9, which is intracellular, is involved in the recognition
sequence of bacterial DNA (CpG oligodeoxynucleotides)
(9). All of these TLRs signal via the adaptor molecule
myeloid differentiation primary response 88 (MyD88)
gene, although TLR4 may alternatively signal through
an MyD88-independent pathway (7,9). TLRs function as
dimers and often use coreceptors, such as CD14, to
assist in pathogen recognition. Specifically, CD14 inter-
acts with TLR4- and TLR2-containing dimeric complexes
to transduce activation signals in response to bacterial
pathogens (11).
Recognition of pathogen components and the sub-
sequent activation of intracellular signaling pathways lead
to the synthesis and release of proinflammatory cyto-
kines, such as tumor necrosis factor-alpha (TNF-a),
interleukin (IL)-1, and IL-8, as well as anti-inflammatory
cytokines, such as IL-10 (7). The expression patterns of
TLRs in different cell types may be an important
regulatory mechanism of the innate immune response to
different pathogens.
The mechanism by which leukocytes clear microorgan-
isms is a complex process that involves the production of
chemokines, rolling, adhesion, and cell migration to the site
of infection (12). This process involves chemokine recep-
tors, such as CXCR2 (13), and the expression of receptors,
such as CD11b and CD66b, which are involved in the
activation, migration, and adhesion of neutrophils (14).
This study tested the hypothesis that the regulation of
the cellular functions of monocytes and neutrophils that
occurs during sepsis may partly reflect changes in the
expression of cellular receptors that are involved in the
recognition of microorganisms, cell signaling, chemotaxis,
and cellular adhesion. Thus, we evaluated the dynamics
of CD14 expression on the surface of monocytes; CD66b
and CXCR2 on the surface of neutrophils; and CD11b,
TLR2, TLR4, TLR5, and TLR9 in both cell populations
during the progression of sepsis.
Material and Methods
Patients and healthy volunteers
Patients older than 18 years were included in the first
72 h of diagnosis of sepsis or 48 h following the first organ
dysfunction (severe sepsis) or refractory hypotension
(septic shock). Patients were excluded from the study if
they were infected with human immunodeficiency virus,
had any neoplastic or immunosuppressive disease, or
were participating in any other study protocol. Patients
were enrolled in the intensive care units of three general
hospitals (Sa˜o Paulo, Sı´rio Libaneˆs, and Israelita Albert
Einstein) located in Sa˜o Paulo, Brazil, between January
2008 and December 2009. One healthy control was
included for every two patients. At the three different sites,
patients were monitored for age and gender. They were
grouped according to age and gender, and, for each pair
of patients, one healthy volunteer of the same gender and
with age in the range of 5 years from the patient’s age was
enrolled. In cases of patients older than 65 years, a
control older than 65 years was accepted. The study was
approved by the Institutional Review Boards of these
three institutions. Written informed consent was obtained
from all participants or, in cases in which that was not
possible, from relatives before enrollment in the study
protocol.
Blood sampling
Samples were obtained from septic patients at
admission [day zero (D0), n=77)] and after 7 days of
therapy (D7, n=45). Forty healthy volunteers were
enrolled as the control group. Five milliliters of blood
was drawn from both the healthy volunteers and the
septic patients into EDTA-treated tubes (Becton
Dickinson, UK). Samples were processed within 4 h at
the Laborato´rio de Imunologia, Divisa˜o de Doenc¸as
Infecciosas, Escola Paulista de Medicina, Universidade
Federal de Sa˜o Paulo, Brazil.
Immunophenotyping of monocytes and neutrophils
The expression of cell surface and intracellular
receptors was investigated in whole blood samples. A
total of 100 mL whole blood from patients and healthy
volunteers was transferred to polystyrene tubes (Becton
Dickinson, USA) and stained with the following mono-
clonal antibodies or isotype controls: 5 mL CD66b-
fluorescein isothiocyanate (FITC), 10 mL mIgG2-phycoery-
thrin (PE), 5 mL CD14-peridinin chlorophyll protein (PerCP),
and 2 mL mIgG2b-allophycocyanin (APC) (Tube 1); 5 mL
CD66b-FITC, 10 mL TLR2-PE, 5 mL CD14-PerCP, and
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3 mL CXCR2-APC (Tube 2); 5 mL CD66b-FITC, 20 mL
TLR4-PE, 5 mL CD14-PerCP, and 2 mL CD11b-APC (Tube
3); 5 mL CD14-PerCP and 3 mL CD15-APC (Tube 4); and
6 mL TLR5-FITC, 5 mL CD14-PerCP, and 3 mL CD15-APC
(Tube 5) (Becton Dickinson). Samples were incubated with
fluorochrome-conjugatedmonoclonal antibodies for surface
staining for 15 min in the dark at room temperature. Two
milliliters of lysis solution (Becton Dickinson) was added into
each tube and the samples were incubated for 10 min in the
dark at room temperature, centrifuged at 3184 g for 5 min
at 46C, and washed with 2 mL phosphate-buffered saline
(PBS; 0.15 M PBS: 8.0 g NaCl, 0.2 g KH2PO4, 1.15 g
Na2HPO4, and 0.2 g KCl, in distilled water to 1 L, pH 7.2).
Tubes 1, 2, and 3 were suspended in 0.3 mL PBS with 1%
sodium azide (Sigma, USA) and stored at 2-86C until use.
Tubes 4 and 5 were suspended with 50 mL permeabilization
buffer (PBS with 5% saponin; Sigma). Tube 5 received
1.5 mL TLR9-PE and was incubated at 2-86C in the dark
for 30 min. The samples were washed with 2 mL PBS, and
the cells were suspended in 0.3 mL PBS with 1% sodium
azide and analyzed by flow cytometry.
Acquisition and analysis of flow cytometry data
Flow cytometry was performed with a FACSCalibur
four-color flow cytometer (Becton Dickinson). A total of 5000
events were acquired for monocytes, combining side scatter
and positivity for CD14 staining. To analyze cell surface and
intracellular receptors, monocytes were defined by combin-
ing forward scatter and side scatter parameters and
positivity for CD14, while neutrophils were defined by
combining forward scatter and side scatter parameters
and positivity for CD66b (15) or positivity for CD15. Data
analysis of the expression of TLR2, TLR4, TLR5, TLR9,
CD11b, CXCR2, CD66b, and CD14 receptors was carried
out using the FlowJo software (Tree Star, USA).
Expression of TLR2, TLR4, TLR5, TLR9, and CD11b
was evaluated on monocytes and neutrophils, expression
of CD14 was assessed on monocytes, and expression of
CD66b and CXCR2 was analyzed on neutrophils.
Receptor expression was measured as the geometric
mean fluorescence intensity (GMFI), and the results are
reported as the difference between the fluorescence
obtained with the specific antibodies and isotype controls.
Statistical analysis
The Kolmogorov-Smirnov test was applied to verify
whether a distribution was normal. Continuous variables
are reported as means±SD when the distribution was
normal or as the median and range when the distribution
was not normal. Discrete variables are reported as
percentages. Differences among the groups were tested
with the Mann-Whitney U-test, and comparisons between
patient samples (D7 vs D0) were performed using the
Wilcoxon signed-rank test. P#0.05 was considered to be
significant. These analyses were performed using SPSS
package 13.0 (SPSS Inc. and Predictive Analytics, USA).
Results
Demographic data
The study included a cohort of 77 septic patients who
were admitted to the intensive care units at three large
tertiary hospitals located in the city of Sa˜o Paulo, Brazil,
and who met the criteria for sepsis (n=4), severe sepsis
(n=18), or septic shock (n=55), as previously described
by Bone et al. (1). Demographic data from patients are
shown in Table 1. Forty healthy volunteers matched for
age and gender to the septic patients were included in the
study. The mean age of the healthy volunteers was
56.9±16 years and 23 (57.5%) were males.
The etiology of sepsis was considered as the
microorganisms recovered from the primary site of
infection or in blood cultures. The agents causing sepsis
were identified in almost 50% of the cases: 15.6% of
sepsis were caused by Gram-positive bacteria, 29.9% by
Table 1. Demographic data and outcomes from septic patients
included in the study.
Cohort of septic patients (n=77)
Age (years) 61 ± 17.2
Gender
Male 43 (55.8%)
Female 34 (44.2%)
Stages of sepsis
Sepsis 4 (5.2%)
Severe sepsis 18 (23.4%)
Septic shock 55 (71.4%)
SOFA score 7.8 ± 4
APACHE II score 18 ± 6.1
Inhospital mortality
Survivors 50 (64.9%)
Nonsurvivors 27 (35.1%)
Outcome according to stage at enrollment
Sepsis
Survivors 4 (100%)
Nonsurvivors 0 (0%)
Severe sepsis
Survivors 11 (61.1%)
Nonsurvivors 7 (38.9%)
Septic shock
Survivors 35 (63.6%)
Nonsurvivors 20 (36.4%)
Sources of infection
Respiratory tract 29 (37.7%)
Abdomen 20 (26.0%)
Urinary tract 13 (16.9%)
Skin or soft tissue 5 (6.4%)
Others 10 (13.0%)
Data are reported as means ± SD or number with percent in
parentheses. SOFA: sepsis-related organ failure assessment;
APACHE II: acute physiology and chronic health evaluation.
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Gram-negative bacteria, and 2.6% were mixed infections;
in the remaining cases (51.9%), the etiology could not be
determined.
Expression of receptors in septic patients and
healthy volunteers
Recognition and signaling receptors. The expression
of CD14 on the surface of monocytes was significantly
lower in the septic patients compared to the healthy
volunteers (P=0.001; Figure 1A).
There was no difference in the expression of TLR2
on the surface of monocytes (P=0.915; Figure 1B) or
neutrophils (P=0.615; Figure 2A) in the septic patients
compared to the healthy volunteers. No difference in the
expression of TLR4 on the surface of monocytes was
observed between septic patients and healthy volunteers
(P=0.084; Figure 1C). The expression of this receptor on
neutrophils was similar for septic patients and healthy
volunteers as well (P=0.556; Figure 2B). The expression
of TLR5 on the surface of monocytes in the septic patients
was significantly higher compared to that in the healthy
volunteers (P=0.041; Figure 1D). Similarly, TLR5 expres-
sion on neutrophils in the septic patients was higher than
on neutrophils in the healthy volunteers (P=0.001; Figure
2C). There was no difference in the expression of
intracellular TLR9 in the monocytes of septic patients
and healthy volunteers (P=0.762; Figure 1E). The same
results were observed for the neutrophils of septic
patients and healthy volunteers (P=0.355; Figure 2D).
Chemotaxis and adhesion receptors. There was no
difference in the expression of CD11b on the surface of
monocytes between septic patients and healthy
volunteers (P=0.771; Figure 1F), although CD11b
expression was lower on the surface of neutrophils from
septic patients compared to healthy volunteers (P=0.007;
Figure 2E). Expression of CXCR2 was also lower on
neutrophils from the former group (P=0.001; Figure 2F).
No difference in the expression of CD66b on the surface
of neutrophils was found between the septic patients and
healthy volunteers (median GMFI=102.00, range=33.00-
476.00, andmedianGMFI=95.25, range=10.90-2457.00,
respectively, P=0.769).
Figure 1. Analysis of the expression of surface and intracellular receptors on monocytes from healthy volunteers and septic patients.
Receptor expression was analyzed in histograms and reported as the geometric mean fluorescence intensity (GMFI): CD14 (A), TLR2
(B), TLR4 (C), TLR5 (D), TLR9 (E), and CD11b (F). Data are reported as box plots, medians with 25 to 75% quartiles (box) and mini-
mum and maximum values (bars). Empty circles indicate outliers. *P,0.05 compared to healthy volunteers (Mann-Whitney U-test).
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Expression of receptors at follow-up for septic
patients
Recognition and signaling receptors. There was no
difference in the expression of CD14 on the surface of the
monocytes of septic patients at admission (D0) compared
to samples collected at D7 (Table 2). The expression of
TLR2 on the surface of monocytes did not differ between
the D0 and D7 samples; however, its expression on the
surface of neutrophils was decreased at D7 compared
to D0 (Table 2). TLR4 expression on the surface of
monocytes and neutrophils did not differ between the D0
and D7 samples (Table 2). Additionally, intracellular
expression of TLR9 in both cell types did not change in
the septic patients at follow-up. However, the expression
of TLR5 on the surface of monocytes and neutrophils
decreased after the 7 days of therapy (Table 2).
Chemotaxis and adhesion receptors. There was no
difference in the expression of CD66b on the surface of
neutrophils at enrollment or after 7 days at follow-up (Table
2). Additionally, no difference in the expression of CD11b
on the surface of monocytes and neutrophils of septic
patients was observed between D0 and D7 (Table 2).
Furthermore, the expression of CXCR2 on the surface of
neutrophils did not differ at follow-up (Table 2).
Expression of receptors in septic patients according
to outcome
Recognition and signaling receptors. Expression of
recognition and signaling receptors was evaluated in the
samples from septic patients taken at follow-up and
stratified according to outcome.
There was no difference in the expression of CD14 on
the surface of monocytes from surviving patients at
enrollment (D0; median GMFI=62.00, range=29.60-
181.00) and follow-up (D7; median GMFI=64.00,
range=33.90-155.0; P=0.903). Additionally, no differ-
ences were observed for the nonsurvivors between
samples at admission (D0; median GMFI=68.15,
range=54.00-241.00) and follow-up (median GMFI=
73.65, range=30.60-183.00; P=0.646).
Expression of TLR2 on the surface of the neutrophils
of surviving patients was significantly lower at D7
compared to that at D0 (P=0.001; Figure 3A), while
TLR2 expression on monocytes did not change in these
Figure 2. Analysis of the expression of surface and intracellular receptors on neutrophils from healthy volunteers and septic patients.
Receptor expression was analyzed in histograms and reported as the geometric mean fluorescence intensity (GMFI): TLR2 (A), TLR4
(B), TLR5 (C), TLR9 (D), CD11b (E), and CXCR2 (F). Data are reported as box plots, medians with 25 to 75% quartiles (box) and mini-
mum and maximum values (bars). Empty circles indicate outliers. *P,0.05 compared to healthy volunteers (Mann-Whitney U-test).
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patients (median GMFI=26.86, range=6.64-135.60; med-
ian GMFI=23.90, range=6.37-72.34; D0 and D7, respec-
tively; P=0.127). Expression of TLR2 on the surface of
monocytes (median GMFI=25.32, range=7.82-83.98;
median GMFI=19.37, range=9.21-107.20; D0 and D7,
respectively; P=0.609) and neutrophils did not change at
follow-up in nonsurvivors (P=0.796; Figure 3A). Expression
of TLR4 on the surface of neutrophils from patients that
survived decreased significantly at D7 compared to D0
(P=0.020), while no difference was found in nonsurvivors
(P=0.501; Figure 3B). Additionally, no difference was found
in the expression of TLR4 on monocytes between D0 and
D7 from surviving septic patients (median GMFI=12.60,
range=2.35-38.50; median GMFI=10.34, range=1.82-
83.70; D0 and D7, respectively; P=0.922) or nonsurvivors
(median GMFI=10.66, range=2.85-43.51; median
GMFI=13.66, range=2.51-31.00; D0 and D7, respectively;
P=0.756). There was no difference in the expression of
intracellular TLR9 between D0 and D7 in survivors for both
monocytes (median GMFI=153.43, range=19.71-668.26;
median GMFI=160.43, range=58.10-398.90; D0 and D7,
respectively) and neutrophils (median GMFI=31.37,
range=16.48-441.47; median GMFI=142.76,
range=34.75-250.78; D0 and D7, respectively; P=0.233
Table 2. Expression of receptors at baseline and follow-up of the septic patients.
n D0 D7
Monocytes
CD14 32 64.25 (29.6-266.00) 67.35 (30.60-183.00)
TLR2 45 25.65 (6.64-135.60) 23.02 (6.37-107.20)
TLR4 45 12.19 (2.35-43.51) 11.36 (1.82-83.70)
TLR5 12 15.15 (3.96-42.55) 8.97 (2.49-47.51)*
TLR9 25 175.13 (19.71-668.92) 160.43 (48.82-398.90)
CD11b 45 137.92 (1.74-736.70) 188.5 (21.37-947.19)
Neutrophils
TLR2 45 7.53 (1.27-26.42) 5.09 (0.62-28.01)*
TLR4 45 6.62 (1.55-28.72) 5.37 (0.97-30.37)
TLR5 12 30.81 (5.07-159.30) 14.87 (2.89-87.69)*
TLR9 25 150.49 (16.48-441.47) 142.40 (34.75-299.04)
CD66b 32 86.65 (33.00-476.00) 78.0 (19.60-261.00)
CD11b 45 122.96 (6.36-597.21) 105.44 (12.33-965.69)
CXCR2 45 66.68 (0.37-319.63) 84.51 (6.45-317.39)
Data are reported as median percent and range of geometric mean fluorescence intensity. D: day. * P,0.05 compared to D0 (Wilcoxon
signed-rank test).
Figure 3. Expression of TLR2, TLR4, and CXCR2 surface receptors on neutrophils from surviving septic patients (n=29) and
nonsurvivors (n=16) at D0 and D7. Surface marker expression was analyzed in histograms and reported as the geometric mean
fluorescence intensity (GMFI): TLR2 (A), TLR4 (B) and CXCR2 (C). Data are reported as box plots, medians with 25 to 75% quartiles
(box) and minimum and maximum values (bars). Empty circles indicate outliers. D: day. *P,0.05 compared to D0 from the same group
(Wilcoxon signed-rank test).
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and P=0.955). Furthermore, there was no difference in the
expression of TLR9 in monocytes and neutrophils in the
nonsurvivor group at D0 (median GMFI=206.68,
range=97.21-497.33; median GMFI=186.96, range=
84.57-546.72, respectively) and D7 (median GMFI=
165.12, range=48.82-280.48; median GMFI=136.34,
range=45.90-299.00, respectively; P=0.059 and
P=0.203 for monocytes and neutrophils, respectively).
Chemotaxis and adhesion receptors. The expression
of CD66b on the surface of neutrophils from survivors
(median GMFI=84.70, range=45.90-476.00; median
GMFI=78.90, range=19.60-261.00; D0 and D7,
respectively) and nonsurvivors (median GMFI=136.50,
range=33.00-241 .00 ; med ian GMFI=57.95 ,
range=48.90-136.00; D0 and D7, respectively) did not
change between D0 and D7 (P=0.498 and P=0.139,
respectively, for survivors and nonsurvivors). Expression
of CD11b on the surface of monocytes did not change
between D0 (median GMFI=137.86, range=1.74-
393.75) and D7 (median GMFI=188.19, range=23.43-
549.40) in survivors (P=0.294). Similar results were
observed for expression of this receptor on the surface
of neutrophils from survivors (median GMFI=110.74,
range=6.36-423.52; median GMFI=92.32, range=
23.87-423.52; D0 and D7, respectively; P=0.304).
Additionally, expression of this receptor did not change
at follow-up for nonsurvivors when both cell populations,
monocytes (median GMFI=159.24, range=35.34-
736.70; median GMFI=302.57, range=21.37-947.19;
D0 and D7, respectively; P=0.301), and neutrophils
(median GMFI=135.60, range=35.94-453.00; median
GMFI=170.84, range=12.33-965.69; D0 and D7,
respectively; P=0.569) were evaluated. Expression of
CXCR2 on the surface of neutrophils was higher at D7
compared to D0 for the patients that survived (P=0.031).
However, the expression of this receptor on the surface of
neutrophils did not change at follow-up for nonsurvivors
(P=0.952; Figure 3C).
Discussion
Our results demonstrate that the cellular receptors
expressed on neutrophils and monocytes that are involved
in pathogen recognition, cell signaling, migration, and
adhesion to endothelial cells are differentially regulated in
septic patients compared to healthy volunteers.
In the present study, the expression of mCD14 on the
surface of monocytes was lower in septic patients
compared to healthy volunteers, which corroborates
previous reports (16,17). We and others found decreased
expression of mCD14 on monocytes and higher levels of
sCD14 in plasma from septic patients compared to
healthy volunteers (16). Conversely, preserved mCD14
expression on monocytes and even increased expression
on neutrophils from septic patients have been reported
(18,19).
Modulation of the expression of mCD14 on monocytes
from septic patients is consistent with its modulation in in
vitro experiments. Jorgensen et al. (20) reported that PGN
increased the expression of CD14, while LPS decreased
its expression. In a previous study, we found a biphasic
pattern of CD14 modulation following LPS stimulation,
with increased expression in the first 6 h of stimulation
followed by decreased expression after 6 and 24 h of
incubation (21). The changes in CD14 expression that are
observed with sepsis and in LPS in vitro experiments
illustrate that the cellular response to LPS and other
products that use CD14 as a pattern recognition receptor
may be modulated during infection.
CD66b is a glycoprotein involved in the activation,
adhesion, and migration of neutrophils (14). In the present
study, the expression of CD66b did not differ between all
conditions studied. This result differs from a previously
published study from our group (15), which showed higher
expression of CD66b on the surface of neutrophils of
septic patients compared to healthy volunteers and the
results obtained by Muller Kobold et al. (22), which
demonstrated that CD66b is differentially expressed in
septic patients according to outcome. This discrepancy
may reflect differences in the populations studied and the
complexity of immune regulation in sepsis.
During the last few years, many studies evaluating
TLR pathways in the context of sepsis have been
published (reviewed in Refs. 6 and 7). In the present
study, expression of TLR2 and TLR4 on the surface of
neutrophils and monocytes did not differ between septic
patients and healthy volunteers. The lack of modulation of
TLR2 and TLR4 expression on monocytes and neutro-
phils is in agreement with previous studies from our group
that included patients in different stages of sepsis (15,16).
In contrast to our findings, others have found an
upregulation of TLR2 expression on monocytes and
neutrophils in septic patients compared to the control
group (23). Despite the upregulation of TLR2, as well as
TLR4, no differences were found in response to TLR2
and TLR4 agonists in septic patients in that study (23).
Expression of TLR2 on the surface of neutrophils of septic
patients decreased after 7 days at follow-up in our study.
Interestingly, expression of this receptor on neutrophils
decreased in the patients who survived while expression
remained stable in those who died. Additionally, expres-
sion of TLR4 on neutrophils decreased at follow-up in
survivors, while no differences were observed in the
whole cohort. Decreased expression of TLR2 and TLR4
on the surface of neutrophils of survivors might be
associated with the control of inflammation. In contrast,
Schaaf et al. (24) showed an association between death
and decreased expression of TLR2 on the surface of
monocytes and lower production of IL-6, TNF-a, and IL-10
in septic patients. Thus, it is difficult to conclude whether
the dynamics of TLR2 expression on monocytes and
neutrophils from septic patients influences the prognosis
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of these patients and which mechanisms are involved.
TLR5 recognizes bacterial flagellin and is expressed in
different cell types, including monocytes, mastocytes,
dendritic cells, and epithelial cells (8,9). It is interesting
that flagellin does not contain an obvious feature that
defines it as non-self or as a pathogen-associated
structure (8). Some studies demonstrate that TLR5 plays
a crucial role in protecting the intestine from pathogens.
For example, TLR5-depleted mice develop exacerbated
colitis in a model of spontaneous colitis (25). In the
present study, the expression of TLR5 was higher among
septic patients compared to healthy volunteers; in
addition, TLR5 expression decreased after 7 days at
follow-up for septic patients.
TLR9 recognizes unmethylated CpG motifs that are
present in bacterial DNA (26). Similar to TLR3 and TLR7,
TLR9 recognizes microbial and modified nucleic acids in
the endosome (9). Expression of TLR9 did not differ
among septic patients and healthy volunteers in our study,
and the sample size was small for evaluating expression
of TLR9 according to outcome. Experimental studies
support an important role for TLR9 in sepsis. Plitas et al.
(27) demonstrated increased bacterial clearance in
TLR9–/– mice subjected to cecal ligation and puncture
CLP-related peritonitis compared with wild-type animals.
The authors also showed increased survival in wild-type
animals when an inhibitory CpG sequence that blocks
TLR9 was administered just before CLP. Another study
employing the CLP model showed that TLR9–/– mice do
not demonstrate neutrophil migration failure and present a
low systemic inflammatory response and a high survival
rate (28).
Thus, regarding TLR expression, TLR5 was increased
on monocytes and neutrophils from septic patients and
TLR2 and TLR4 were decreased on neutrophils at follow-
up for surviving patients. However, despite these changes,
it is likely that the functional changes in monocytes and
neutrophils that are observed during sepsis are not directly
linked to the modulation of expression of TLR (reviewed in
Refs. 6 and 7). This is consistent with previous results
obtained by our group and others. We found a dynamic
modulation of cytokine production by monocytes (16) and
reactive oxygen species generation by monocytes and
neutrophils (29,30) during the different stages of sepsis
that is not associated with the expression of TLR2 and
TLR4. The lower production of inflammatory cytokines by
monocytes from septic patients resembles the functional
changes seen in alternatively activated macrophages;
accordingly, increased expression of markers of alternative
activation – CD166 andCD206 – were found onmonocytes
from septic patients (31). Furthermore, we found that
TLR signaling pathway genes are regulated differently in
mononuclear cells and neutrophils of septic patients. Mo-
nonuclear cells presented downregulation in septic shock,
predominantly in the nuclear factor kappa B (NFkB) path-
way, while neutrophils showed predominantly upregulated
genes throughout the stages of sepsis (32). These and
other studies support the intracellular regulation of TLR cell
signaling in sepsis (6), which is corroborated by studies of
LPS-induced tolerance. Accordingly, the modulation of
gene expression in tolerant cells in response to LPS
appears to occur independently of changes in TLR
expression, as demonstrated by Foster et al. (33) and by
a study from our group (34). Integrins are crucial to
leukocyte migration during the inflammatory response. The
expression of CD11b on the surface of neutrophils was
lower among the septic patients compared to the healthy
volunteers in our cohort, which is in agreement with
previous results (19). The lower expression of CD11b on
neutrophils could be a result of receptor internalization, as
reported by previous studies (35). Tansho-Nagakawa et al.
(19) suggested that the decreased CD11b expression
observed in septic patients might also be due to an
increased percentage of circulating immature neutrophils.
In contrast, Lin et al. (36) found increased expression of
CD11b on the surface of neutrophils of septic patients
compared to healthy volunteers. We did not find differ-
ences in CD11b expression between survivors and
nonsurvivors in this study, which contrasts with a study
by Muller Kobold et al. (22), which showed lower
expression of CD11b on the neutrophils of septic patients
who died compared with those who survived. The expres-
sion of CD11b on monocytes did not differ between the
septic patients and healthy volunteers, which is in agree-
ment with our previous study on severe sepsis and septic
shock patients (16). In contrast, LPS induces the expres-
sion of CD11b on human monocytes and neutrophils in
vitro (21) and on monocytes following intravenous injection
in healthy volunteers (37).
CXCR2 is a chemokine receptor involved in neutrophil
migration to sites of injury. In the present study, we
observed lower CXCR2 expression in the neutrophils of
septic patients compared to healthy volunteers. These
results are in agreement with previous results (38). The
decreased expression of CXCR2 may occur in response to
the high levels of circulating chemokines in a possible
negative-feedback mechanism that could be present in
patients with advanced stages of sepsis (38). Additionally,
a previous study published by our group demonstrated
lower expression of this receptor on the surface of
neutrophils from healthy volunteers after stimulation with
LPS in vitro (21), and Juffermans et al. (39) reported that
the administration of low doses of LPS in vivo induces a
decrease in both the CXCR1 and CXCR2 receptors on
circulating granulocytes in the whole blood of healthy
individuals. Reduced neutrophil migration to the site of
infection is associated with a worse prognosis during
sepsis. This reduced expression may be an attempt by the
host to limit excessive inflammation induced by granulo-
cytes at the site of infection but may also be detrimental. A
study from Rios-Santos et al. (40) demonstrated that mice
subjected to CLP show deficient neutrophil migration to
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the site of infection during severe sepsis, which is
associated with decreased expression of CXCR2 on the
cell surface. In the present study, the expression of
CXCR2 differed between survivors and nonsurvivors at
follow-up. CXCR2 expression was higher on the surface of
neutrophils on D7 for survivors, suggesting that reversal of
the downregulation of expression of this receptor may be
important to restore neutrophil function.
In conclusion, a dynamic modulation of cell surface
receptor expression was found when septic patients were
compared to healthy volunteers. The expression of CXCR2
and CD11b was lower, while the expression of TLR5 was
higher on the surface of neutrophils in septic patients
compared to healthy volunteers. With regard to monocytes,
CD14 expression was lower and TLR5 expression was
higher in septic patients compared with healthy volunteers.
When evaluated at follow-up, expression of TLR2 and TLR5
on neutrophils and expression of TLR5 on monocytes were
significantly lower after 7 days of therapy compared to
admission. Interestingly, expression of the TLR2, TLR4 and
CXCR2 receptors on neutrophils at follow-up was differen-
tially modulated in survivors and nonsurvivors. Expression
of TLR2 and TLR4 on the surface of neutrophils was
diminished while expression of CXCR2 was augmented at
follow-up for survivors and remained stable for nonsurvi-
vors. These results may reflect cellular reprogramming, a
mechanism that is possibly involved in decreasing inflam-
mation and preserving infection control. The lack of
modulation of TLR2 and TLR4 expression on the mono-
cytes of septic patients compared to healthy volunteers
highlights the important role of the intracellular mechanisms
of inflammatory control.
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